Re: Fabry trial news, Halifax and Alberta's Children't Hospital slated....
|
2
|
Resverlogix Corp.
|
Jun 14, 2017 02:07PM
|
Re: Extension of debenture!
|
4
|
Resverlogix Corp.
|
Apr 19, 2022 10:41PM
|
Re: Extension of debenture!
|
5
|
Resverlogix Corp.
|
Apr 20, 2022 09:47AM
|
Re: Extension of debenture!
|
3
|
Resverlogix Corp.
|
Apr 20, 2022 10:02AM
|
Re: Extended Betonmace trial
|
3
|
Resverlogix Corp.
|
Apr 21, 2017 03:15PM
|
Re: Extended Betonmace trial
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 11:23PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 11:18AM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 05:09PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 07:04PM
|
Re: Exposure in Motley Fool....
|
3
|
Resverlogix Corp.
|
Oct 08, 2019 07:29PM
|
Re: Exposure in Motley Fool....
|
3
|
Resverlogix Corp.
|
Oct 08, 2019 07:38PM
|
Re: Exempt
|
2
|
Resverlogix Corp.
|
Mar 24, 2021 04:32PM
|
Re: Exempt
|
2
|
Resverlogix Corp.
|
Mar 24, 2021 03:05PM
|
Re: Excerpt of a recent Bloomberg article......
|
2
|
Resverlogix Corp.
|
Jan 15, 2020 05:58PM
|
Re: EVERSANA: Partnering & Licensing.
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 12:42PM
|
Re: Events
|
2
|
Zenith Epigenetics
|
Apr 26, 2017 10:51AM
|
Re: Events
|
3
|
Zenith Epigenetics
|
Apr 25, 2017 02:57PM
|
Re: Events
|
1
|
Zenith Epigenetics
|
Apr 25, 2017 03:17PM
|
Re: Events
|
5
|
Zenith Epigenetics
|
Apr 26, 2017 12:31AM
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
2
|
Resverlogix Corp.
|
May 27, 2019 03:40PM
|